Newsroom

Newsroom

Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch

Blog
Read More

The Breakroom Video Series

Blog
Read More

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

Press Release
Read More

Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics

Blog
Read More

Is IHC going to exhaust our archival blocks the way single gene testing used to?

Blog
Read More

NeoGenomics announces speaker program, ‘Minimal Residual Disease in Colorectal Cancer’

Blog
Read More

NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022

Press Release
Read More

IVDR at NeoGenomics

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients